Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7NMA

Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide

Summary for 7NMA
Entry DOI10.2210/pdb7nma/pdb
Descriptor14-3-3 protein sigma, Amot-p130 phosphopeptide (pS175), CHLORIDE ION, ... (5 entities in total)
Functional Keywordsprotein-peptide complex, signaling protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight29913.09
Authors
Centorrino, F.,Ottmann, C. (deposition date: 2021-02-23, release date: 2022-01-12, Last modification date: 2024-11-13)
Primary citationCentorrino, F.,Andlovic, B.,Cossar, P.,Brunsveld, L.,Ottmann, C.
Fragment-based exploration of the 14-3-3/Amot-p130 interface.
Curr Res Struct Biol, 4:21-28, 2022
Cited by
PubMed Abstract: The modulation of protein-protein interactions (PPIs) has developed into a well-established field of drug discovery. Despite the advances achieved in the field, many PPIs are still deemed as ' targets and the design of PPIs stabilizers remains a significant challenge. The application of fragment-based methods for the identification of drug leads and to evaluate the ' of the desired protein target has seen a remarkable development in recent years. In this study, we explore the molecular characteristics of the 14-3-3/Amot-p130 PPI and the conceptual possibility of targeting this interface using X-ray crystallography fragment-based screening. We report the first structural elucidation of the 14-3-3 binding motif of Amot-p130 and the characterization of the binding mode and affinities involved. We made use of fragments to probe the ' of the 14-3-3/Amot-p130 composite binding pocket. Here we disclose initial hits with promising stabilizing activity and an early-stage selectivity toward the Amot-p130 motifs over other representatives 14-3-3 partners. Our findings highlight the potential of using fragments to characterize and explore proteins' surfaces and might provide a starting point toward the development of small molecules capable of acting as .
PubMed: 35036934
DOI: 10.1016/j.crstbi.2021.12.003
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon